An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues.

By Chang-Gong Liu, George A. Calin, Brian Meloon, Nir Gamliel, C. Sevignani, M. Ferracin, C. Dumitru, M. Shimizu, S. Zupo, M. Dono and 4 more. Proceedings of the National Academy of Sciences of the United States of America, 2004

972 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/cde7b10619a54868cfbdacf99d051bc631bb86d7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Molecular Biology

Citations in the corpus

Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer (2008, methodology): “extremely little information is available regarding their physiological and pathological roles. Until now, the most common method for quantifying miRNA was Northern blotting. A number of different approaches to quantify miRNAs have been described, including microarrays [”
microRNAs as oncogenes and tumor suppressors. (2007, background): “Several laboratories have modified DNA microarray technology to form miRNA microarray technology (Babak et al., 2004; Barad et al., 2004; Liang et al., 2005; Liu et al., 2004; Nelson et al., 2004a,b; Thomson et al., 2004).”
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues (2006, background): “Using mammalian microarray technology, comprehensive analysis of miRNA expression will help us better understand the relationship between aberrant gene expression and diseases (Liu et al., 2004; Liang et al., 2005).”
Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. (2008, methodology): “Expression profiling was performed using total RNA with the human/mouse miR expression array (V 4.0) and analyzed as described ( 14 ).”
Regulation of miRNA expression during neural cell specification (2005, background): “A complete description of miRNA expression during stem cell differentiation will require the application of array technology (Krichevsky et al., 2003; Liu et al., 2004).”
Real-time quantification of microRNAs by stem–loop RT–PCR (2005, methodology): “Less abundant miRNAs routinely escape detection with technologies such as cloning, northern hybridization (31) and microarray analysis (32,33).”
Widespread deregulation of microRNA expression in human prostate cancer (2008, background): “Volinia et al. (2006) used total mRNA, which would include precursor miRNAs, for labeling and spotted oligonucleotides that detect both precursor and mature miRNAs (Liu et al., 2004).”
An overview of microRNAs (2015, methodology): “Early studies were performed using microarray, RT-PCR, and bead-based hybridization (Luminex) platforms, while more recent studies have used NGS-based profiling[117, 162-167].”
Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. (2005, background): “Other systems have recently been described for the expression profiling of miRNAs (Babak et al. 2004; Liu et al. 2004; Miska et al. 2004; Nelson et al. 2004; Thomson et al. 2004).”
MicroRNA gene expression deregulation in human breast cancer. (2005, methodology): “RNA labeling and hybridization on miRNA microarray chips was done as previously described (10).”
A microRNA DNA methylation signature for human cancer metastasis (2008, methodology): “miRNA microarray profiling was conducted as described (23).”
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. (2008, background): “39 In this study, there were few patients with favorable cytogenetics, such as inv(16)[4] and t(15;17)[4].”